Thursday, April 6, the eve of World Health Day celebrated this year under the theme of public health, a delegation from the commission of inquiry into the shortage of drugs visited in Calvados pour visit two industrial sites where key consumer healthcare products affected by supply disruptions are manufactured. The purpose of this trip was to better identify sources of shortages at all stages of drug production.
Tant in Lisieuxin the largest factory in production of Doliprane of Sanofithan in Hérouville Saint-Clair, where saline laboratories Gilbertshe was able to take the measure of efforts made by the teamsall along the production lines, to meet the strong growth in demand, in a context of spectacular increases in the cost of raw materials and energy.
She saw how the relocation of the production of raw materialsin particular of active ingredients, was a source of fragility for the entire sector, as well as for the health security of the French.
